Learning | Cardiovascular diseases

Learning

Cancer-associated thrombosis

Venous thromboembolism is a complication of cancer that pharmacists should understand to ensure that their patients have the best possible outcomes. …

Published: 8 September 2020

Learning

Acute coronary syndrome: risk factors, diagnosis and treatment

This overview describes the different management options for acute coronary syndrome and how pharmacists can support patients with the condition.…

Published: 13 March 2020

Learning

Managing hypertension: the role of diet and exercise

It is well known that high blood pressure increases the risk of heart attacks and strokes. However, there are lifestyle interventions that pharmacists can encourage patients to implement to reduce this risk.…

Published: 14 February 2020

Learning

Heart failure, older people and frailty

Diagnosis of heart failure and frailty can often be masked by other long-term conditions, making the delivery of treatment goals complicated.…

Published: 12 July 2019

Learning

Prevention of venous thromboembolism in hospitalised patients

Pharmacists should note the National Institute for Health and Care Excellence’s updated guidance on use of pharmacological thromboprophylaxis in a range of hospitalised patient groups.…

Published: 5 February 2019

Learning

Pathophysiology and management of heart failure

Ensuring patients are optimised on maximum tolerated doses of medicines in heart failure with reduced ejection fraction is essential in minimising the burden of the condition.…

Published: 6 December 2018

Supported content

Learning

How to support people with aphasia with medicines optimisation

Aphasia is a communication disability, most often caused by stroke, which occurs when the language centres of the brain are damaged. Pharmacists and healthcare professionals should be aware of how the communication needs of people with aphasia vary based on the severity of the condition, and how the…

Published: 13 February 2018

Learning

Stroke: classification and diagnosis

In light of the many pressures currently facing the NHS, as well as an ever increasing ageing population, pharmacists and healthcare professionals should be aware of the risk factors for stroke, its classification and diagnosis.…

Published: 10 January 2018

Learning

Chronic oedema: treatment and the impact of prescribed medicines

Early diagnosis of lower limb oedema is crucial to prevent early oedema becoming chronic. Pharmacists and other healthcare professionals are ideally placed to identify patients on certain medicines at higher risk of oedema, and should be aware of signs of chronic oedema when assessing pati…

Published: 7 June 2017

Learning

Non-statin drugs for the management of dyslipidaemia in adults

The role of non-statin drugs, including ezetimibe, fibrates, bile acid binders, nicotinic acid derivatives, omega-3 fatty acid supplements and PCSK9 inhibitors, for the management of dyslipidaemia in adults.…

Published: 12 May 2016